APA (7th ed.) Citation

NA, C., JM, S., A, S., C, T., TG, R., JM, S., . . . DT, R. (2023). Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes. Digestive diseases and sciences, 68(4), 1464. https://doi.org/10.1007/s10620-022-07716-0

Chicago Style (17th ed.) Citation

NA, Cohen, et al. "Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes." Digestive Diseases and Sciences 68, no. 4 (2023): 1464. https://doi.org/10.1007/s10620-022-07716-0.

MLA (9th ed.) Citation

NA, Cohen, et al. "Endo-histologic Normalization Is Achievable with Tofacitinib and Is Associated with Improved Clinical Outcomes." Digestive Diseases and Sciences, vol. 68, no. 4, 2023, p. 1464, https://doi.org/10.1007/s10620-022-07716-0.